Michael T Parsons

35PUBLICATIONS
487CO-AUTHORS
Predictive and prognostic markersCancer geneticsProteomics and metabolomicsGene expression (incl. microarray and other genome-wide approaches)Oncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Mar 23, 2026
Cancer genomic profiling predicts pathogenicity of <i>BRCA1</i> and <i>BRCA2</i> variants.

Olga Kondrashova, Rebecca L Johnston, Michael T Parsons

|Aug 06, 2025
The SeqSplice multiplexed minigene splicing assay for characterization and quantitation of variant-induced <i>BRCA1</i> and <i>BRCA2</i> splice isoforms.

Daffodil M Canson, Michael T Parsons, Gemma Moir-Meyer

|May 24, 2025
Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification.

Maria Zanti, Denise G O'Mahony, Michael T Parsons

|Nov 25, 2024
Childhood, adolescent, and young adulthood cancer risk in BRCA1 or BRCA2 pathogenic variant carriers.

Shuai Li, Laura Madanat-Harjuoja, Goska Leslie

|Oct 14, 2024
Unrecognised actionability for breast cancer risk variants identified in a national-level review of Australian familial cancer centres.

Cristina Fortuno, Elisa J Cops, Aimee L Davidson

|Sep 16, 2024
Analysis of more than 400,000 women provides case-control evidence for <i>BRCA1</i> and <i>BRCA2</i> variant classification.

Maria Zanti, Denise G O'Mahony, Michael T Parsons

Pageof 6

Frequent Collaborators

19 joint publications

Paul James

18 joint publications

Joe Dennis

18 joint publications

Goska Leslie

18 joint publications

Amanda B Spurdle